Congress has 7 big ideas to cut drug prices. Here’s how they work. image

Vox, January 17, 2019
by Dylan Scott, quoting Rachel Sachs


Read the Full Article

From the article:

"One irony of the ongoing drug prices debate, says Rachel Sachs, an associate professor at Washington University in St. Louis, is that the drug industry opposition to more modest proposals like this, targeted to particular bad actors and actions, is driving Democrats to embrace more ambitious and potentially disruptive proposals.

'When the industry opposes even those bills designed to rein in bad actors — those engaging in collusive settlements or other anticompetitive practices — it is not surprising that Democrats would seek to introduce more extreme ideas,' she told me."

Read more here!

pharmaceuticals rachel sachs regulation